[{"id":"9461158e-5d26-4049-990e-1b882bc14200","acronym":"","url":"https://clinicaltrials.gov/study/NCT06295952","created_at":"2024-03-06T21:33:56.543Z","updated_at":"2024-07-02T16:35:06.703Z","phase":"Phase 2","brief_title":"A Study of Pasireotide in People With Prolactinoma","source_id_and_acronym":"NCT06295952","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Signifor (pasireotide)"],"overall_status":"Recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 02/27/2024","start_date":" 02/27/2024","primary_txt":" Primary completion: 02/01/2027","primary_completion_date":" 02/01/2027","study_txt":" Completion: 02/01/2027","study_completion_date":" 02/01/2027","last_update_posted":"2024-05-01"},{"id":"a6d2ab39-a519-4fdb-aca6-2f51916bba32","acronym":"","url":"https://clinicaltrials.gov/study/NCT01468532","created_at":"2021-01-18T06:06:48.742Z","updated_at":"2024-07-02T16:36:32.814Z","phase":"Phase 1/2","brief_title":"Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer","source_id_and_acronym":"NCT01468532","lead_sponsor":"Barbara Ann Karmanos Cancer Institute","biomarkers":" IGF1 • CHGA","pipe":"","alterations":" ","tags":["IGF1 • CHGA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • prednisone • Signifor (pasireotide) • Signifor LAR (pasireotide long acting release)"],"overall_status":"Completed","enrollment":" Enrollment 18","initiation":"Initiation: 10/01/2011","start_date":" 10/01/2011","primary_txt":" Primary completion: 07/20/2017","primary_completion_date":" 07/20/2017","study_txt":" Completion: 07/20/2017","study_completion_date":" 07/20/2017","last_update_posted":"2021-03-25"},{"id":"5c198dbc-6083-4c67-b2d1-7c3c064510c7","acronym":"","url":"https://clinicaltrials.gov/study/NCT01620138","created_at":"2021-02-09T07:54:52.437Z","updated_at":"2024-07-02T16:37:29.629Z","phase":"Phase 2/3","brief_title":"Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas","source_id_and_acronym":"NCT01620138","lead_sponsor":"Universidade Federal do Rio de Janeiro","biomarkers":" PRL","pipe":"","alterations":" ","tags":["PRL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Signifor (pasireotide)"],"overall_status":"Completed","enrollment":" Enrollment 21","initiation":"Initiation: 03/01/2010","start_date":" 03/01/2010","primary_txt":" Primary completion: 06/01/2012","primary_completion_date":" 06/01/2012","study_txt":" Completion: 06/01/2012","study_completion_date":" 06/01/2012","last_update_posted":"2016-08-22"}]